SCHEMBL17058765

SCHEMBL17058765

CC(C)C[C@H](N)CB1OC2CC3C[C@H]([C@@H]2O1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23864846 0.78 ANPEP (0.41) —
SCHEMBL8257773 0.78 ANPEP (0.41) —
SCHEMBL15865680 0.78 ANPEP (0.41) —
SCHEMBL23864904 0.78 — —
SCHEMBL22694558 0.78 — —
SCHEMBL13951136 0.73 — —
SCHEMBL13815186 0.73 ANPEP (0.33) —
SCHEMBL24490416 0.72 — —
SCHEMBL14551811 0.70 — —
SCHEMBL19678630 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505787-B2 Process for preparing of bortezomib CIPLA LIMITED (IN) 2016-11-29 — — US disclosed
US-9505787-B2 Process for preparing of bortezomib CIPLA LIMITED (IN) 2016-11-29 — — US disclosed
US-20150246935-A1 Process for Preparing of Bortezomib CIPLA LIMITED (IN) 2015-09-03 — — US disclosed
US-20150246935-A1 Process for Preparing of Bortezomib CIPLA LIMITED (IN) 2015-09-03 — — US disclosed
Send feedback